FDA accepts approval application for AstraZeneca’s vandetanib
LONDON The Food and Drug Administration has accepted AstraZeneca’s regulatory application for an investigational cancer drug, the Anglo-Swedish drug maker said Thursday.
AstraZeneca announced the FDA’s acceptance of its application for vandetanib, a drug for treating patients with advanced medullary thyroid cancer. The agency gave the drug priority review status and expected to take action on it in January.
More than 44,000 new cases of thyroid cancer will be diagnosed in the United States this year, according to the American Cancer Society, and medullary thyroid cancer accounted for 5% of thyroid cancers overall.
Casey joins A&P’s board
MONTVALE, N.J. Grocer A&P has announced the election of Thomas Casey to its board of directors.
Casey has more than 24 years of experience in financial management and strategic planning. During his career, he has served as a strategic financial adviser to companies in the retail entertainment, food and drug, convenience store, food wholesale and foodservice industries. During his tenure at Deutsche Bank Securities, Casey was responsible for the banks’ retail industry relationships in North America. He also has held financial and investment banking positions with Citigroup, Merrill Lynch, Blockbuster and Dillon Read & Co.
“I would like to welcome Tom to the board. We are excited to have his extensive financial knowledge and experience to help us lead our comprehensive turnaround. I am looking forward to working with Tom and the board of directors to create value for our shareholders,” stated Christian Haub, executive chairman of the company.